These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26509963)

  • 1. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
    Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
    Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
    Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
    World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Zheng XM; Zhang P; Liu MH; Chen P; Zhang WB
    Int J Oncol; 2019 Feb; 54(2):443-454. PubMed ID: 30483762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
    Arai T; Okato A; Yamada Y; Sugawara S; Kurozumi A; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Med; 2018 May; 7(5):1988-2002. PubMed ID: 29608247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
    Zhao Y; Miao G; Li Y; Isaji T; Gu J; Li J; Qi R
    PLoS One; 2014; 9(2):e87938. PubMed ID: 24498407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression.
    Bhagirath D; Yang TL; Tabatabai ZL; Shahryari V; Majid S; Dahiya R; Tanaka Y; Saini S
    Carcinogenesis; 2019 Jul; 40(5):633-642. PubMed ID: 30874288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3.
    Zhang W; Han S; Yuan Y; Xu M; Ding A; Li M
    Biochem Genet; 2024 Aug; 62(4):2652-2666. PubMed ID: 38001392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circSLC8A1 Acts as a Tumor Suppressor in Prostate Cancer via Sponging miR-21.
    Wang D; Yan S; Wang L; Li Y; Qiao B
    Biomed Res Int; 2021; 2021():6614591. PubMed ID: 33869627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets.
    Singh VK; Rajak N; Singh Y; Singh AK; Giri R; Garg N
    Ann Surg Oncol; 2024 Jul; 31(7):4795-4808. PubMed ID: 38758485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway.
    Fang LL; Sun BF; Huang LR; Yuan HB; Zhang S; Chen J; Yu ZJ; Luo H
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1.
    Xu S; Ge J; Zhang Z; Zhou W
    Oncol Rep; 2018 Mar; 39(3):1454-1460. PubMed ID: 29328406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer.
    Rana PS; Wang W; Markovic V; Szpendyk J; Chan ER; Sossey-Alaoui K
    Cancer Res Commun; 2023 Jan; 3(1):160-174. PubMed ID: 36968231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer.
    Chen M; Zou C; Tian Y; Li W; Li Y; Zhang D
    Oncogene; 2024 May; 43(21):1594-1607. PubMed ID: 38565944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles derived from stored red blood cell suspensions enhance invasion and migration of lung cancer cells by miR1246 and miR150-3p.
    Cheng Z; Kong Y; Xu H; Xiao L; Tian L; Liu Z
    Vox Sang; 2024 Aug; 119(8):809-820. PubMed ID: 38839077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research of the unrecognised functions of miR-375 in prostate cancer cells.
    Goztepe M; Eroglu O
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):212-218. PubMed ID: 38650131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway.
    Zhang X; Yu T; Gao G; Xu J; Lin R; Pan Z; Liu J; Feng W
    Biomol Biomed; 2023 Dec; 24(4):840-847. PubMed ID: 38153517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
    Khan AP; Poisson LM; Bhat VB; Fermin D; Zhao R; Kalyana-Sundaram S; Michailidis G; Nesvizhskii AI; Omenn GS; Chinnaiyan AM; Sreekumar A
    Mol Cell Proteomics; 2010 Feb; 9(2):298-312. PubMed ID: 19955085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.
    Nohata N; Hanazawa T; Kikkawa N; Sakurai D; Fujimura L; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nakagawa M; Katayama A; Harabuchi Y; Okamoto Y; Seki N
    Br J Cancer; 2011 Sep; 105(6):833-41. PubMed ID: 21847129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer.
    Camargo JA; Viana NI; Pimenta R; Guimarães VR; Dos Santos GA; Candido P; Ghazarian V; Romão P; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Trarbach EB; Reis ST
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.